DOI: 10.21276/ajptr
Fri, 24 May 2019

A Novel Bioinformatics Approach: to Design Novel 1, 4-Benzothiazine Derivatives for the Treatment of Hypertension

Amit Rai1*, Vinit Raj1, Deepak Kumar1

1. Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University (A Central University)Vidya Vihar, Raebreli Road, Lucknow-226025(U.P.), India.


Angiotensin I-converting enzyme (ACE) is a key therapeutic target for combating hypertension and related cardiovascular diseases. ACE inhibitory novel designed substituted 1, 4-benzothiazine derivatives offer the prospect of enhanced potency, high specificity, and no or low side effect. Novel 1,4-benzothiazine derivatives were designed keeping in view the structural requirement of pharmacophore and Quantitatively structure Activity Relationship (QSAR).In the docking study, the most active compounds of the series were, AR 1, AR 2 and AR 3 exhibited good binding properties. Result reveals that the protein-ligand interaction energy of derivatives AR 1, AR 2 and AR 3 were -7.51 kcal/mol, -8.80 kcal/mol and -7.63 kcal/mol, which is slightly greater than the marketed antihypertensive Losartan drug as -5.51 kcal/mol, so that the derivatives have satisfactory affinity with established hypertensive receptor namely Angiotensin converted enzyme II. A computational study was also carried out including prediction of pharmacokinetic properties, toxicity and bioactivity studies. The percentage of absorption (%ABS) was calculated and observed that all titled compounds exhibited a better %ABS %ABS ranging 90.54, 91.42 and 90.55 respectively and compared than standard Losartan drug as %ABS 77.06.Although other pharmacological parameters were better than the standard drug. The above observation suggested that these compounds would serve as better lead compound for antihypertensive screening for future drug design perspective.

Keywords: 1, 4-benzothiazine derivatives, Anti hypertension activity, Computational study and ACE-II.

[PDF]   Viewed: 951   Downloaded: 91
  • Call for paper

    American Journal of PharmTech Research (AJPTR) is a peer-reviewed, bimonthly official international journal allowing access to abstracts and full-text.



  • Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.


  • Article Statastics

    American Journal of PharmTech Research (AJPTR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission

    American Journal of PharmTech Research (AJPTR) is one of the International open access journal devoted to various disciplines in science and technology.


web counter
web counter